What Is Posterior Fossa Syndrome After Brain Surgery?

Posterior fossa syndrome is a cluster of neurological problems that can strike children after surgery to remove a brain tumor from the back and lower part of the skull. Its hallmark is mutism, a sudden loss of speech that typically appears a day or two after what may have been a technically successful operation. Roughly one in four children who undergo posterior fossa tumor surgery develop the syndrome, and while most eventually regain speech, the recovery is slow and the broader effects on thinking, movement, and emotional control can persist for years.

What the Syndrome Looks Like

The most recognizable feature is the abrupt disappearance of speech. A child who was talking before surgery goes silent, sometimes completely. But mutism is only the most conspicuous symptom. The full picture often includes poor coordination and low muscle tone, making it hard for a child to sit up, walk, or use their hands with any precision. Emotional outbursts, sometimes described as emotional lability, are common and can be intense, with a child swinging rapidly between crying and apparent indifference. Cranial nerve problems may cause difficulty swallowing, double vision, or facial weakness. Some children develop urinary incontinence or retention. Others show changes in mood and behavior that go well beyond what you would expect from a scared, recovering child.¹

The reported incidence ranges from about 8% to 31% of children undergoing posterior fossa tumor surgery, depending on the study and how strictly the syndrome is defined. A widely cited estimate puts the figure at roughly 25%.² Part of the variation comes from the fact that researchers have used different names and criteria over the years. Some use “cerebellar mutism syndrome” to mean the same thing, while others reserve that label for cases where mutism is present and consider the broader constellation of symptoms to be a separate entity. An international consensus effort has worked to standardize the definition, but in practice the terminology still overlaps.³

Timing and Onset

One of the more unsettling aspects of posterior fossa syndrome is its delayed appearance. Surgery may go smoothly, the child may wake up and even speak in the first hours afterward, and then a day or two later the silence sets in. The typical delay is one to two days, though onset can range from one to twelve days after the operation, with an average around three and a half days.⁴ This latency is part of why the syndrome caught the medical community off guard for so long: families and surgeons may initially believe everything went well, only to face a frightening decline shortly afterward.

The latent period has also been a clue to researchers trying to understand the underlying cause. An injury that takes a day or more to manifest is unlikely to be a simple matter of cutting the wrong tissue during surgery. Something more gradual is happening in the brain’s circuitry after the operation, and that observation has steered the science toward explanations involving swelling, inflammation, and disrupted signaling between the cerebellum and the rest of the brain.

Why It Happens

The cerebellum, the structure that sits in the posterior fossa, does far more than coordinate movement. It has dense two-way connections with the cerebral cortex, the part of the brain responsible for language, planning, attention, and emotional regulation. The critical highway connecting the cerebellum to the cortex runs through a bundle of nerve fibers called the efferent cerebellar pathway, which exits through the superior cerebellar peduncles and relays signals upward through the thalamus to the frontal and other cortical regions.

Research using advanced brain imaging has shown that children who develop posterior fossa syndrome tend to have damage to both sides of this pathway, particularly in the proximal segment near the cerebellum. When these fibers are injured, the cerebellum effectively loses its ability to communicate with the cortex.⁵ The result is a phenomenon sometimes called cerebellocerebral diaschisis: the cortex, deprived of its normal input from the cerebellum, essentially goes quiet in regions that depend on that input. Brain perfusion studies have shown that children with the syndrome have reduced blood flow in the cerebral cortex, especially the frontal lobes, compared to children who had the same surgery but did not develop the syndrome.⁶

A systematic review confirmed this pattern: cerebral perfusion is measurably lower in children with the syndrome after surgery compared to those without it.⁷ Whether reduced blood flow is the cause of the symptoms or a downstream marker of the disconnection is still debated, but the diaschisis model is the leading explanation. It neatly accounts for why the syndrome involves not just movement problems (which you would expect from cerebellar damage alone) but also speech, emotion, and cognition, all of which depend on frontal cortical function.

Which Children Are Most Vulnerable

Not every child who has posterior fossa surgery develops the syndrome, and tumor type is one of the strongest predictors. Medulloblastoma carries the highest risk, with one study finding that about 21% of children with medulloblastoma developed PFS, compared to 13% for ependymoma and only 1% for astrocytoma. Every child who developed the syndrome in that study had a tumor that directly involved the brainstem.⁸ The brainstem involvement is probably key because removing a tumor that invades or compresses the brainstem is more likely to disrupt the nearby efferent cerebellar pathways.

Medulloblastomas tend to grow in the midline of the cerebellum, right where those critical output fibers converge. Astrocytomas, by contrast, more often grow off to one side and are less invasive, which may explain their far lower risk. This also means the risk is not just about the surgery itself but about the tumor’s relationship to vulnerable structures before the surgeon even makes an incision.

Does the Surgical Approach Make a Difference

For years, surgeons debated whether one operative route into the fourth ventricle, where many of these tumors sit, might be safer than another. The two main options are the transvermian approach, which involves splitting the cerebellar vermis down the middle, and the telovelar approach, which enters through a natural crevice at the bottom of the cerebellum and theoretically avoids cutting through functional tissue. Because the vermis sits in the heart of the cerebellum and is involved in motor coordination, it seemed logical that cutting through it would increase the risk of posterior fossa syndrome.

The evidence, however, has not borne this out. A multicenter study of 67 patients, combined with a meta-analysis incorporating over 300 additional patients from other studies, found no significant difference in neurological complications between the two approaches.⁹ A separate systematic review and meta-analysis reached the same conclusion, finding that mutism, cranial nerve deficits, gait disturbance, and need for fluid drainage were all statistically similar between the two routes.¹⁰ And another study focused specifically on cerebellar mutism syndrome risk confirmed no clear advantage of either approach in preventing the condition.¹¹

This is somewhat counterintuitive and has led researchers to conclude that the syndrome is driven less by the specific path a surgeon takes and more by the extent of tumor infiltration, the degree of retraction and manipulation required to remove the tumor, and the resulting disruption to the efferent cerebellar pathways regardless of which angle the surgeon approaches from. A child with a large midline medulloblastoma invading the brainstem faces significant risk no matter how the surgeon gets to the tumor.

Predicting Risk Before and During Surgery

Because surgical approach alone does not determine risk, researchers have turned to imaging tools to try to identify vulnerable children before surgery begins. Diffusion tensor imaging, a type of MRI that maps the brain’s white matter connections, has revealed that children who go on to develop PFS already show differences in the connectivity of their brain pathways before the operation. These preoperative differences, particularly in the pathways connecting the cerebellum to the thalamus and cortex, may reflect damage the tumor itself has already caused to surrounding tissue.¹²

Other work has examined whether imaging done during the operation itself can serve as an early warning system. Researchers have investigated whether diffusion abnormalities visible on intraoperative MRI, particularly in the cerebellar output pathways and vermis, might predict which children will develop the syndrome in the days that follow.¹³ The hope is that real-time monitoring could allow surgeons to adjust their strategy mid-operation if they detect emerging damage to critical fibers.

Along similar lines, intraoperative neurophysiological monitoring is an emerging tool. By electrically stimulating the cerebellum and recording the response in the motor cortex during surgery, teams can track whether the pathways connecting the two are still intact. Early feasibility studies have confirmed that this kind of monitoring works in the operating room, though it has not yet been shown to prevent the syndrome.¹⁴ The general principle that neurophysiological monitoring provides real-time feedback on neural function during posterior fossa surgery is well established and makes the procedure safer in other respects as well.¹⁵

Treatment and the Road to Recovery

There is no established cure for posterior fossa syndrome, and management remains largely supportive. Speech eventually returns for most children, but the recovery is slow. When it does come back, speech is typically dysarthric, meaning slurred and effortful, and the improvement stretches over many months.¹⁶ During recovery, most children display features of dysarthria, though only some show the specific speech patterns that are classically cerebellar in origin.¹⁷

Rehabilitation tends to involve a coordinated team of speech-language pathologists, physical therapists, and occupational therapists. An international survey found that while specific techniques varied somewhat by region, the overall approach, including the dose, frequency, and intensity of therapy, was broadly similar across countries, suggesting a rough informal consensus even in the absence of formal guidelines.¹⁸ Augmentative communication devices, picture boards, and other nonverbal tools are often introduced early to help the child communicate during the mute phase, which can also reduce frustration and emotional distress for the child and their family.

Pharmacological options are limited and still considered experimental. Zolpidem, a sleep medication that happens to act on certain brain receptors involved in inhibition and cortical activation, has been tried in small studies. In one cohort of nineteen patients, mutism scores improved in about a third of those treated for at least 48 hours, and improvement rates climbed to roughly two-thirds among those who continued for two weeks. Around three-quarters of families reported subjective improvement in communication and interaction. Side effects were mild, limited to drowsiness in a few children and brief irritability and insomnia in one.¹⁹ Bromocriptine, a dopamine agonist used in Parkinson’s disease, has also been reported as effective in a small case series of pediatric patients.²⁰ Neither medication has been tested in a randomized controlled trial for this purpose, so their role remains uncertain.

Long-Term Cognitive Consequences

The most concerning aspect of posterior fossa syndrome may not be the acute mutism, which does tend to resolve, but what follows in the years afterward. Children who develop PFS perform worse on a range of cognitive tests compared to children who had the same type of tumor and surgery but did not develop the syndrome. A recent large study of medulloblastoma survivors found that those with a history of PFS scored substantially lower on measures of focused attention, motor processing speed, visuomotor processing speed, and cognitive flexibility, even after adjusting for differences in age, treatment intensity, and other variables.²¹ The deficits were not trivial: processing speed scores in the PFS group averaged more than three standard deviations below the population norm, a level of impairment that substantially affects daily functioning.

A prospective multi-institutional study tracked cognitive outcomes at one, three, and five years after diagnosis and found that children with PFS had lower scores on intellectual ability, processing speed, attention, working memory, and spatial reasoning at every time point. Processing speed remained stably low, while attention and working memory actually declined further over time rather than improving.²² That pattern of progressive decline in certain domains suggests that the initial cerebellar injury may disrupt brain development in ways that compound as the child grows and faces increasing cognitive demands at school.

These findings carry practical weight. A child returning to school after medulloblastoma treatment who also had PFS may need specialized educational support, neuropsychological monitoring, and accommodations that go beyond what other brain tumor survivors require. Families and teachers who assume the child will “catch up” once the mutism resolves may be surprised by the persistence and breadth of the cognitive effects.

Posterior Fossa Syndrome in Adults

Nearly all research on posterior fossa syndrome focuses on children, and for good reason: it occurs far more often in pediatric patients. More than 200 pediatric cases had been described in the literature when one review of adult cases was published, whereas adult reports remained extremely rare.²³ When it does occur in adults, it shares many features with the pediatric version, including mutism and emotional changes, but the causes can be more varied. Adult cases have been linked not only to tumor surgery but also to other posterior fossa pathology. One documented case involved a 32-year-old man with a large inflammatory lesion in the pons and midbrain related to multiple sclerosis, who developed the classic combination of coordination problems, speech disturbance, concentration difficulty, and impaired decision-making.

Why children are so much more susceptible is not entirely clear. One possibility is that the developing brain relies more heavily on intact cerebellar-cortical connections for speech and cognitive functions that have not yet become fully established or lateralized. In adults, these circuits may be more robust or redundant, making the system more resilient to disruption. This is still speculative, but the dramatic age difference in incidence is one of the more striking features of the syndrome and continues to drive research into how the cerebellum contributes to brain development.

The Emotional Side

Discussions of posterior fossa syndrome tend to focus on mutism and cognitive outcomes, but the emotional and behavioral dimension deserves its own attention. Emotional lability, meaning rapid, unpredictable shifts in mood, is one of the defining features and can be deeply distressing for both the child and the family. Children may laugh or cry without apparent provocation, become irritable or withdrawn, or display personality changes that feel alien to parents who knew them well before surgery.²⁴

These emotional symptoms are now understood as part of what researchers call the cerebellar cognitive affective syndrome, a broader concept recognizing that the cerebellum plays a role in regulating emotion and personality, not just movement. The posterior fossa syndrome overlaps substantially with this broader entity, and some researchers have argued that disentangling the different components, including arousal, cranial nerve problems, motor deficits, vestibular dysfunction, cognitive changes, emotional dyscontrol, and mutism, each potentially linked to different neural circuits, is essential for developing targeted treatments.²⁵ For now, the emotional symptoms are managed with a combination of behavioral support, family counseling, and patience, though pharmacological approaches for agitation and emotional regulation are sometimes needed in the acute phase.

For families navigating this experience, the emotional toll is compounded by the fact that these children are also cancer patients who typically face radiation and chemotherapy after surgery. The syndrome can interfere directly with a child’s ability to participate in post-surgical treatment. A child who cannot swallow safely may need alternative nutrition. A child in emotional crisis may struggle to cooperate with procedures. The practical consequences of PFS extend well beyond the neurological symptoms themselves and into every aspect of the child’s cancer care and recovery.